DUNE

Dune Acquisition Corporation DUNE

Trading inactive

DUNE
Dune Acquisition Corporation ESLA
Estrella Immunopharma, Inc. GBRG
Goldenbridge Acquisition Limited AMAO
American Acquisition Opportunity Inc. CVII
Churchill Capital Corp VII CLIN
Clean Earth Acquisitions Corp. KYCH
Keyarch Acquisition Corporation ASCB
A SPAC II Acquisition Corporation

Net profit

EBITDA

P/E Ratio

Capitalization

Performance

Periode DUNE ESLA GBRG AMAO CVII CLIN KYCH ASCB
6M -59.54 % 70.71 % -40.62 % -27.80 % -6.37 % -52.28 % 0.00 % -1.93 %
YTD 0.00 % 50.89 % -40.97 % -26.57 % -4.86 % 0.00 % 0.00 % 1.54 %
1Y -58.80 % 53.64 % -39.68 % -26.50 % -4.40 % -50.69 % 0.00 % 1.54 %
3Y -59.98 % -83.50 % -37.65 % -25.53 % 2.78 % -49.19 % -58.33 % 10.25 %
5Y -59.98 % -82.67 % -37.65 % -25.53 % 1.42 % -49.19 % -57.95 % 13.37 %
10Y -59.98 % -82.67 % -37.65 % -25.53 % 1.42 % -49.19 % -57.95 % 13.37 %
From the beginning -59.98 % -82.67 % -37.65 % -25.53 % 1.42 % -49.19 % -57.95 % 13.37 %

Dividend